查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495985

样品製备市场 – 2024 年至 2029 年预测

Sample Preparation Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022 年样品製备市场价值为 6,820,288,000 美元，预计复合年增长率为 4.89%，到 2029 年市场规模将达到 9,552,129,000 美元。

将化学和生物样品转化为可以直接插入仪器进行分析的形式的过程称为样品製备。样品製备市场包括用于製备生物和化学样品的产品，用于分析原料以检测不需要的元素。样品製备流程和产品广泛应用于製药领域、生物技术、实验室、食品工业和化学工业。化学和生物领域的成长和进步正在推动样品製备市场的成长。

样品製备在药物研究中的重要性和应用是全球样品製备市场成长潜力的关键因素之一。与化学和生物学部分相关的所有调查和分析都得到适当的样品製备过程和分析的支持。领先公司和政府为促进化学、生物和食品行业的研究和分析领域而进行的大量投资正在推动全球市场上样品製备产品的市场规模。

小型化、自动化、高性能、新样品製备设备与现有分析仪器整合的可能性、溶剂用量和时间的减少也正在推动全球市场样品製备产品的市场规模。此外，在化学和生物研究中获得准确结果的样品分析效率也推动了样品製备市场的成长。

製药和化学领域新技术开发的主要市场参与企业之间的竞争也推动了样品製备产品的市场规模，样品製备产品对于在研究和实验中获得准确的结果发挥关键作用。政府的支持和製药领域龙头企业的资金活性化了疫情期间的研究活动，从而带动了样本製备市场的成长。

市场驱动因素：

  • 样品製备在药物研究中日益重要，正在推动市场发展。

样品製备过程在药物研究中的关键作用是推动全球市场成长的关键因素之一。药物分析是使用各种高性能分析仪器进行的，但大多数仪器不能直接处理复杂的基质，因此提取和分离感兴趣的分析物的样品製备步骤是很困难的。国际公司和政府机构对製药和医学研究的资助正在促进研究活动，并增加样品製备产品的市场需求和价值。

英国製药工业协会2017年的报告显示，全球製药业多年来在研发方面的投入，从2006年的1,081亿美元增加到2016年的1,567亿美元。製药领域研究活动的不断增加也扩大了与之相关的样品製备市场的市场规模。

  • 健康和生物研究领域投资的增加预计将推动市场激增

对健康和生物研究领域的投资增加正在扩大全球市场上样品製备产品的市场规模。 2018 年德国研究基金会 (DFG) 为德国定序中心提供的 1,730 万美元资助是生物研究领域的投资之一。

亚太和中东地区新兴国家在医学研究领域的巨额投资预计也将在预计的几年内扩大样本製备市场的市场规模。

北美地区占据了主要市场份额。

据估计，北美在样品製备市场中占据很大份额。美国是生物製药的主要市场之一，在那里进行的研发在北美地区占据了很大的市场占有率。由于其先进的医疗基础设施、高研发活动、生物技术和製药行业的存在、严格的监管标准以及对诊断测试和个性化医疗的关注，北美预计将在样品製备市场中占据很大份额。合作研究、生物样本库计画、技术进步、生命科学研究资金增加、市场竞争。

该地区先进的医疗基础设施、高研发活动、这些行业的存在以及严格的监管标准促进了复杂的样品製备技术的采用。对诊断测试和个人化医疗的日益关注也推动了对准确、高效的样品製备方法的需求。学术机构、研究中心和产业相关人员之间的合作将进一步加速尖端样品製备技术的发展。北美样品製备市场的竞争格局也刺激了市场的成长。

主要发展

  • 2023 年 1 月 - 科学家们开发了一种新方法来分析抑制Chaperone蛋白 HSP90 所造成的破坏，这是癌症治疗的关键策略。利用多维蛋白质组学技术，我们对 HSP90 抑制的影响获得了独特的见解，检测了蛋白质-蛋白质关联的变化，并在清单中添加了新的蛋白质。这项认知将指南未来开髮用于癌症治疗的下一代 HSP90 抑制剂的努力，并加深我们对 HSP90 抑製作为健康老化策略潜力的理解。
  • 2022 年 10 月 - 沃特世公司推出 Extraction+ 连网型设备 ，这是一款适用于 Waters(TM) Andrew+(TM) 移液机器人的软体控制产品，可透过固相萃取自动製备生物、食品、法医学和环境样品。这种免持的自动化方法使科学家能够在每个样品组上缩短时间的工作时间，并降低使用者变异的风险。该设备由智慧型帮浦、用于固定小柱或洗脱板的歧管以及用于在 SPE 净化过程中创建和控制压力梯度的软体组成。 Waters 现已在全球提供 Extraction+Connected 设备。
  • 2022 年 10 月 - nRichDX 宣布推出两款用于液态切片的新产品：革命循环游离总核酸 (cfTNA) 试剂盒(TM) 和 cfDNA 参考标准产品。这些产品旨在帮助研究人员开发液态切片检测方法，并与 nRichDX 的 Revolution Sample Prep System(TM) 相容。 Revolution 样本製备系统用于从血浆或尿液样本中提取高产量的稀有 cfDNA，这些样本是液态切片检测中使用的主要分析物。 cfDNA 参考标准品基于单核 DNA，包括一管 cfDNA 萃取对照品，可解冻并用于测量 cfDNA 萃取的产量和效率。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章样品製备市场：副产品

  • 介绍
  • 装置
    • 市场机会和趋势
    • 成长前景
    • 地理收益
    • 样品製备工作站/系统
    • 液体处理系统
    • 萃取系统
    • 其他乐器
  • 消耗品
  • 样品製备套件
  • 其他的

第六章样品製备市场：依应用分类

  • 介绍
  • 蛋白质体学
  • 基因组学
  • 表观基因
  • 其他的

第七章 样品製备市场：依最终使用者分类

  • 介绍
  • 药品
  • 生物技术
  • 临床试验诊断
  • 其他的

第八章样品製备市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Illumina
  • Merck Millipore（Merck KGaA）
  • Danaher Corporation
  • Roche
  • Perkinelmer, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
简介目录
Product Code: KSI061611954

The sample preparation market was evaluated at US$6,820.288 million for the year 2022 and is projected to grow at a CAGR of 4.89%, reaching a market size of US$9,552.129 million by the year 2029.

A process for converting chemical and biological samples into a form that can be directly inserted into an instrument for analysis is termed sample preparation. The sample preparation market includes products that are used to prepare biological and chemical samples to analyze raw materials to detect undesirable elements. Sample preparation processes and products are widely used in the pharmaceutical sector, biotechnology, laboratories, food industry, and chemical industry. The growth and progress in the chemical and biological sectors are promoting the sample preparation market growth.

The importance and application of sample preparation in pharmaceutical research are one of the major factors giving potential to the global sample preparation market growth. Every research and analysis associated with the chemical and biological sector is supported by a proper sample preparation process and analysis. The large investments of major companies and governments in promoting the research and analysis sector of the chemical, biological, and food industries is boosting the market value of sample preparation products in the global market.

Miniaturization, automation, high-throughput performance, the potential of new sample preparation instruments to integrate with existing analytical instruments, and a reduction in solvent volume and time are also pushing the market value of sample preparation products in the global market. The efficiency showcased by sample analysis in giving accurate results in chemical and biological research is also fuelling the sample preparation market growth.

The competition of major market players for developing new technologies in the pharmaceutical and chemical field is also hiking the market value of sample preparation products, as they have a vital role in giving accurate results in research and experiments. The support offered by the government and funds offered by major players in the pharmaceutical field fuelled the research activities during the pandemic period, resulting in the sample preparation market growth.

Market Drivers:

  • The rising importance of sample preparation in pharmaceutical research poses to propel the market.

The vital role of the sample preparation process in pharmaceutical research is one of the major factors driving its market growth globally. Pharmaceutical analyses are performed utilizing various high-performance analytical instruments, even though most analytical devices cannot directly handle complex matrixes, necessitating a sample preparation step to extract and isolate the analytes of interest. The funding given for pharmaceutical and medical research by international companies and governmental organizations is boosting research activities, which also increases the market demand and value for sample preparation products.

According to a 2017 report by the Association of the British Pharmaceutical Industry, the global pharmaceutical industry has invested in research and development over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016. The increasing rate of research activities in the pharmaceutical field is also hiking the market value of the sample preparation market associated with it.

  • Increasing investments in the health and biological research sector are expected to surge the market.

The increasing investments in the health and biological research sector are hiking the market value of sample preparation products in the global market. The funding of 17.3 million USD by the German Research Foundation (DFG) in 2018 for German sequencing centers is one of the investments in the biological research sector.

The significant investments made by developing countries in the Asia Pacific and the Middle East region in the medical and healthcare research sector are also expected to push the market value of the sample preparation market in the forecasted years.

The North American region holds a major share of the market.

North America is estimated to hold a significant market share in the sample preparation market. As the United States is one of the major markets for biopharmaceuticals, the research, and developments taking place in the country contributed to the large market share of the North American region. North America is expected to hold a significant share of the sample preparation market due to its advanced healthcare infrastructure, high research and development activities, presence in the biotechnology and pharmaceutical industries, strict regulatory standards, increasing focus on diagnostic testing and personalized medicine, collaborations, biobanking initiatives, technological advancements, increased funding for life sciences research, and market competitiveness.

The region's advanced healthcare infrastructure, high research and development activities, presence of these industries, and strict regulatory standards contribute to the adoption of sophisticated sample preparation technologies. The growing focus on diagnostic testing and personalized medicine also drives the demand for accurate and efficient sample preparation methods. Collaborations between academic institutions, research centers, and industry players further foster the development of cutting-edge sample preparation technologies. The competitive landscape in the North American sample preparation market also stimulates market growth.

Key Developments:

  • January 2023- Scientists developed a new method to analyze the disruption caused by inhibiting the chaperone protein HSP90, a key strategy for cancer treatment. They used a multi-dimensional proteomic technique to gain a unique view of the effects of HSP90 inhibition, detecting changes in protein-protein associations and adding new proteins to the list. This understanding guides future efforts to develop next-generation HSP90 inhibitors for cancer treatment and advance our understanding of HSP90 inhibition's potential as a strategy for healthier aging. HSP90 is crucial for stabilizing or activating around 300 proteins in cells, many of which are oncogenic.
  • October 2022- Waters Corporation launched the Extraction+ connected device, a software-controlled product for the Waters(TM) Andrew+(TM) Pipetting Robot, which automates the preparation of biological, food, forensics, and environmental samples via solid phase extraction. This hands-free, automated approach saves scientists up to four hours of bench time for each sample set and reduces the risk of user-to-user variability. The device consists of a smart pump, a manifold for holding cartridges or elution plates, and software for creating and controlling pressure gradients during SPE cleanup procedures. The Extraction+ Connected Device is now available worldwide from Waters.
  • October 2022- nRichDX introduced two new products for liquid biopsy applications: the Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit(TM) and the cfDNA Reference Standard products. These products are designed to aid researchers in developing liquid biopsy assays and are compatible with nRichDX's Revolution Sample Prep System(TM). The Revolution Sample Prep System is used for high-yield extraction of rare cfDNA from plasma or urine samples, which is the primary analyte used in liquid biopsy assays. The cfDNA Reference Standard, based on mono-nucleosomal DNA, contains tubes of thaw-and-use cfDNA extraction controls to measure the yield and efficiency of cfDNA extraction.

Segmentation:

By Product

  • Instruments
  • Sample Preparation Workstations/Systems
  • Liquid Handling Systems
  • Extraction Systems
  • Other Instruments
  • Consumables
  • Sample Preparation Kits
  • Other Products

By Application

  • Proteomics
  • Genomics
  • Epigenomics
  • Others

By End Users

  • Pharmaceuticals
  • Biotechnology
  • Laboratory Diagnostics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. SAMPLE PREPARATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Instruments
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
    • 5.2.4. Sample Preparation Workstations/Systems
    • 5.2.5. Liquid Handling Systems
    • 5.2.6. Extraction Systems
    • 5.2.7. Other Instruments
  • 5.3. Consumables
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Sample Preparation Kits
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Other Products
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. SAMPLE PREPARATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Proteomics
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Genomics
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Epigenomics
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. SAMPLE PREPARATION MARKET BY END USERS

  • 7.1. Introduction
  • 7.2. Pharmaceuticals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Biotechnology
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Laboratory Diagnostics
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Others
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness

8. SAMPLE PREPARATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Application
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. UK
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Application
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Application
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. India
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. Japan
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Agilent Technologies Inc.
  • 10.2. Bio-Rad Laboratories Inc.
  • 10.3. Illumina
  • 10.4. Merck Millipore (Merck KGaA)
  • 10.5. Danaher Corporation
  • 10.6. Roche
  • 10.7. Perkinelmer, Inc.
  • 10.8. Norgen Biotek Corporation
  • 10.9. Qiagen N.V